A shadow economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.
Experimental Drug Gaining Traction Online
The experimental drug, which is still in research studies, is being advertised by online personalities for its supposed fat-burning effects. Viewers are urged to contact these profiles privately for supplier links, while also receiving discount codes.
Active Trade on Social Networks
Separately, a robust market exists on messaging services, where communities with numerous of participants share comparison images, administration instructions and assertions of next-day UK delivery. Sellers market the drug there before directing customers to other platforms for purchases.
Understanding Retatrutide
This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.
Healthcare Experts Express Worries
However, doctors and pharmacists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting substances of uncertain source.
Several experts said the demand for the experimental drug could be linked to the increasing price of approved slimming products such as Mounjaro.
Legal Position and Implementation
Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the British medical regulations.
Several influencers attempt to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach pharmaceutical, marketing, and customer laws, potentially leading to penalties, prosecution or imprisonment.
Service Reaction and Material Removal
According to the social media company, the platform has removed problematic material and banned associated keywords and search suggestions. The organization stated it was committed to keeping the service secure and allocating resources in strengthening compliance measures.
Digital Marketplace Operations
Investigations also found groups with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of users, filled with photos of slimming results, positive testimonials and detailed guides for mixing or injecting at home.
Within moments of joining one community, a seller posted contact information, where most transactions occur. The seller provided an guidebook and promised delivery within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, health issues or past usage.
Product Information and Costs
Within these groups, posts show black plastic parcels with Royal Mail stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with sterile water, or ready-to-use pens usually priced at 160 pounds for 20mg. When asked how much time a injector should last, sellers give contradictory responses varying between a several days to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for Telegram stated it actively moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering substances they can’t verify. Even if the science behind retatrutide is sound, these digital products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to social media. But fake treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.
Her team has previously seen individuals harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Producer Position
A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may expose users to possibly serious medical dangers”.
